120 related articles for article (PubMed ID: 7818577)
1. Increased release of bone sialoprotein into synovial fluid reflects tissue destruction in rheumatoid arthritis.
Saxne T; Zunino L; Heinegård D
Arthritis Rheum; 1995 Jan; 38(1):82-90. PubMed ID: 7818577
[TBL] [Abstract][Full Text] [Related]
2. Release of cartilage and bone macromolecules into synovial fluid: differences between psoriatic arthritis and rheumatoid arthritis.
Mânsson B; Gülfe A; Geborek P; Heinegård D; Saxne T
Ann Rheum Dis; 2001 Jan; 60(1):27-31. PubMed ID: 11114278
[TBL] [Abstract][Full Text] [Related]
3. Cartilage and bone macromolecules in knee joint synovial fluid in rheumatoid arthritis: relation to development of knee or hip joint destruction.
Månsson B; Geborek P; Saxne T
Ann Rheum Dis; 1997 Feb; 56(2):91-6. PubMed ID: 9068280
[TBL] [Abstract][Full Text] [Related]
4. Relations between synovial fluid and serum concentrations of osteocalcin and other markers of joint tissue turnover in the knee joint compared with peripheral blood.
Salisbury C; Sharif M
Ann Rheum Dis; 1997 Sep; 56(9):558-61. PubMed ID: 9370881
[TBL] [Abstract][Full Text] [Related]
5. Serum and synovial fluid osteocalcin (bone gla protein) levels in joint disease.
Campion GV; Delmas PD; Dieppe PA
Br J Rheumatol; 1989 Oct; 28(5):393-8. PubMed ID: 2790398
[TBL] [Abstract][Full Text] [Related]
6. Tissue-derived macromolecules and markers of inflammation in serum in early rheumatoid arthritis: relationship to development of joint destruction in hands and feet.
Fex E; Eberhardt K; Saxne T
Br J Rheumatol; 1997 Nov; 36(11):1161-5. PubMed ID: 9402859
[TBL] [Abstract][Full Text] [Related]
7. Serum and synovial fluid osteocalcin in rheumatic diseases.
Mattei JP; Ferrera V; Boutsen Y; Franceschi JP; Botti D; De Boissezon C; Kaphan G; Roux H
Int J Clin Pharmacol Res; 1992; 12(3):103-7. PubMed ID: 1473875
[TBL] [Abstract][Full Text] [Related]
8. Abnormal osteocalcin binding in rheumatoid arthritis.
Fairney A; Patel KV; Hollings NP; Seifert MH
Ann Rheum Dis; 1990 Apr; 49(4):229-30. PubMed ID: 2339902
[TBL] [Abstract][Full Text] [Related]
9. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
Caspi D; Anouk M; Golan I; Paran D; Kaufman I; Wigler I; Levartovsky D; Litinsky I; Elkayam O
Arthritis Rheum; 2006 Feb; 55(1):53-6. PubMed ID: 16463412
[TBL] [Abstract][Full Text] [Related]
10. Increased concentrations of bone sialoprotein in joint fluid after knee injury.
Lohmander LS; Saxne T; Heinegård D
Ann Rheum Dis; 1996 Sep; 55(9):622-6. PubMed ID: 8882132
[TBL] [Abstract][Full Text] [Related]
11. Levels of hepatocyte growth factor in synovial fluid and serum of patients with rheumatoid arthritis and release of hepatocyte growth factor by rheumatoid synovial fluid cells.
Yukioka K; Inaba M; Furumitsu Y; Yukioka M; Nishino T; Goto H; Nishizawa Y; Morii H
J Rheumatol; 1994 Dec; 21(12):2184-9. PubMed ID: 7699616
[TBL] [Abstract][Full Text] [Related]
12. Alternatively spliced EDA-containing fibronectin in synovial fluid as a predictor of rheumatoid joint destruction.
Shiozawa K; Hino K; Shiozawa S
Rheumatology (Oxford); 2001 Jul; 40(7):739-42. PubMed ID: 11477277
[TBL] [Abstract][Full Text] [Related]
13. Difference in cartilage proteoglycan level in synovial fluid in early rheumatoid arthritis and reactive arthritis.
Saxne T; Heinegård D; Wollheim FA; Pettersson H
Lancet; 1985 Jul; 2(8447):127-8. PubMed ID: 2862321
[TBL] [Abstract][Full Text] [Related]
14. Cartilage and bone metabolism in rheumatoid arthritis. Differences between rapid and slow progression of disease identified by serum markers of cartilage metabolism.
Månsson B; Carey D; Alini M; Ionescu M; Rosenberg LC; Poole AR; Heinegård D; Saxne T
J Clin Invest; 1995 Mar; 95(3):1071-7. PubMed ID: 7533784
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of anti-3-nitrotyrosine antibodies in the joint synovial fluid of patients with rheumatoid arthritis, osteoarthritis and systemic lupus erythematosus.
Khan F; Siddiqui AA
Clin Chim Acta; 2006 Aug; 370(1-2):100-7. PubMed ID: 16513103
[TBL] [Abstract][Full Text] [Related]
16. Quantitation and distribution of vitronectin in synovial fluid and tissue of patients with rheumatic disease.
Rosenblum G; Carsons S
Clin Exp Rheumatol; 1996; 14(1):31-6. PubMed ID: 8697654
[TBL] [Abstract][Full Text] [Related]
17. Osteoprotegerin and the receptor activator of NF-kappa B ligand in the serum and synovial fluid. A comparison of patients with longstanding rheumatoid arthritis and osteoarthritis.
Skoumal M; Kolarz G; Haberhauer G; Woloszczuk W; Hawa G; Klingler A
Rheumatol Int; 2005 Nov; 26(1):63-9. PubMed ID: 15889303
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of immunoreactive bone sialoprotein in osteoporosis: positive relations to established biochemical parameters of bone turnover.
Fassbender WJ; Ruf T; Kaiser HE; Stracke H
In Vivo; 2000; 14(5):619-24. PubMed ID: 11125546
[TBL] [Abstract][Full Text] [Related]
19. [Correlation study between interleukin-17 and ESR and CRP in serum and the synovial fluid of rheumatoid arthritis patients of accumulated dampness-heat obstruction in joints syndrome].
Liu DF; Yan J; Guo MY; Wang C; Hu YH; Yang M; Yun MD; Luo Y; Zhang J; Li H
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Mar; 34(3):272-5. PubMed ID: 24758074
[TBL] [Abstract][Full Text] [Related]
20. Decreased levels of a soluble form of the human adhesion receptor CD58 (LFA-3) in sera and synovial fluids of patients with rheumatoid arthritis.
Hoffmann JC; Räuker HJ; Krüger H; Bayer B; Zeidler H
Clin Exp Rheumatol; 1996; 14(1):23-9. PubMed ID: 8697653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
